Butobarbital, also called butobarbitone or butethal, Soneryl, and Neonal,[1] is a hypnotic drug which is a barbiturate derivative.[2] It was developed by Poulenc Brothers (now part of Sanofi) in 1921.[3]
Clinical data | |
---|---|
Trade names | Soneryl |
AHFS/Drugs.com | International Drug Names |
Routes of administration | By mouth |
ATC code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Liver |
Excretion | Kidney |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.928 |
Chemical and physical data | |
Formula | C10H16N2O3 |
Molar mass | 212.249 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |